| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...885624Z |
| P356 | DOI | 10.1371/JOURNAL.PONE.0085624 |
| P932 | PMC publication ID | 3874028 |
| P698 | PubMed publication ID | 24386484 |
| P5875 | ResearchGate publication ID | 259567479 |
| P2093 | author name string | Yanhong Zhang | |
| Xinbin Chen | |||
| Wensheng Yan | |||
| P2860 | cites work | Effects of common cancer mutations on stability and DNA binding of full-length p53 compared with isolated core domains | Q51186530 |
| Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome | Q52561781 | ||
| Morphogenetic clonal growth of kidney epithelial cell line MDCK | Q69010904 | ||
| Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation | Q70168032 | ||
| A subset of p53-deficient embryos exhibit exencephaly | Q72031963 | ||
| Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy | Q77932308 | ||
| Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome | Q81166001 | ||
| Sarcomatoid renal cell carcinoma is an example of epithelial–mesenchymal transition | Q82047838 | ||
| Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway | Q24302433 | ||
| p53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinoma | Q24306453 | ||
| Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product | Q24310794 | ||
| Role of DeltaNp63gamma in epithelial to mesenchymal transition | Q24632945 | ||
| MDCK Cystogenesis Driven by Cell Stabilization within Computational Analogues | Q27333596 | ||
| Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations | Q27730815 | ||
| Complex networks orchestrate epithelial-mesenchymal transitions | Q29547478 | ||
| Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database | Q29616468 | ||
| Tumor spectrum analysis in p53-mutant mice | Q29617436 | ||
| T antigen is bound to a host protein in SY40-transformed cells | Q29618321 | ||
| p53: puzzle and paradigm | Q29618407 | ||
| Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer | Q30525287 | ||
| Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion | Q30537354 | ||
| Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins | Q33292223 | ||
| Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer | Q33607176 | ||
| The p53 pathway | Q33643359 | ||
| Regulation of the p53 tumor suppressor protein | Q33792315 | ||
| Scatter factors and invasive growth | Q34231968 | ||
| Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes | Q34292432 | ||
| The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth | Q34402080 | ||
| Database of p53 gene somatic mutations in human tumors and cell lines | Q34868968 | ||
| Mutant p53 Disrupts MCF-10A Cell Polarity in Three-dimensional Culture via Epithelial-to-mesenchymal Transitions | Q34963520 | ||
| The MDM2 oncoprotein is overexpressed in rhabdomyosarcoma cell lines and stabilizes wild-type p53 protein. | Q35782290 | ||
| Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. | Q36660357 | ||
| TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes | Q36777326 | ||
| Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis. | Q36993572 | ||
| P63 regulates tubular formation via epithelial-to-mesenchymal transition | Q36998524 | ||
| Biomarkers for epithelial-mesenchymal transitions | Q37209254 | ||
| When mutants gain new powers: news from the mutant p53 field. | Q37582777 | ||
| p53 and its mutants in tumor cell migration and invasion | Q37832072 | ||
| Physical interaction with human tumor-derived p53 mutants inhibits p63 activities. | Q38291171 | ||
| Spatial repression of PCNA by p53 during kidney development | Q38363218 | ||
| Early organogenesis of the kidney | Q39611879 | ||
| Mutant p53(R175H) upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells. | Q39670597 | ||
| p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug | Q39850223 | ||
| Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy. | Q39966300 | ||
| C-Met Proto-Oncogene Expression in Benign and Malignant Human Renal Tissues | Q40883469 | ||
| Modulation of scatter factor/hepatocyte growth factor activity by cell-substratum adhesion | Q41472012 | ||
| Chromosome 17p deletions and p53 mutations in renal cell carcinoma. | Q41545285 | ||
| p53 tumor-suppressor gene: Clues to molecular carcinogenesis | Q41640484 | ||
| Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells | Q42416957 | ||
| Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development | Q42770153 | ||
| Induction of gene amplification as a gain-of-function phenotype of mutant p53 proteins | Q44010460 | ||
| P53 mutations and other prognostic factors of renal cell carcinoma | Q44307459 | ||
| Morphological and biochemical analysis of Rac1 in three-dimensional epithelial cell cultures. | Q46150566 | ||
| Rising incidence of renal cell cancer in the United States | Q46854143 | ||
| TP53 gene mutations in canine osteosarcoma | Q47643652 | ||
| Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue | Q47794980 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e85624 | |
| P577 | publication date | 2013-12-27 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Mutant p53 cooperates with knockdown of endogenous wild-type p53 to disrupt tubulogenesis in Madin-Darby canine kidney cells | |
| P478 | volume | 8 |
| Q48162761 | Necessity of p53-binding to the CDH1 locus for its expression defines two epithelial cell types differing in their integrity. |
| Q35987262 | P73 tumor suppressor and its targets, p21 and PUMA, are required for madin-darby canine kidney cell morphogenesis by maintaining an appropriate level of epithelial to mesenchymal transition |
| Q38746401 | Regulation of the MET oncogene: molecular mechanisms |
| Q35827656 | The ectopic expression of Snail in MDBK cells does not induce epithelial-mesenchymal transition |
| Q55515332 | p53-Dependent and -Independent Epithelial Integrity: Beyond miRNAs and Metabolic Fluctuations. |
Search more.